MLchartDataset catalogue

Verzenio

Term · Oncology and biomedicine · MLC-T-ONC-009222

A drug used alone or with other drugs to treat adults with certain types of hormone-receptor positive, HER2-negative breast cancer. It is also being studied in the treatment of other types of cancer. Verzenio blocks certain proteins, which may help keep cancer cells from growing. It is a type of cyclin-dependent kinase inhibitor. Also called abemaciclib.

Table 1. Record
IdentifierMLC-T-ONC-009222
FieldOncology and biomedicine
Synonymsabemaciclib
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-009222",
  "term": "Verzenio",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with certain types of hormone-receptor positive, HER2-negative breast cancer. It is also being studied in the treatment of other types of cancer. Verzenio blocks certain proteins, which may help keep cancer cells from growing. It is a type of cyclin-dependent kinase inhibitor. Also called abemaciclib.",
  "synonyms": [
    "abemaciclib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/verzenio/"
}

Record 17,205 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.